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ABSTRACT A molecular understanding of volatile anesthetic mechanisms of action will require structural descriptions of
anesthetic-protein complexes. Previous work has demonstrated that the halogenated alkane volatile anesthetics halothane and
chloroform bind to the hydrophobic core of the four-a-helix bundle (Aa2-L38M)2 (Johansson et al., 2000, 2003). This study
shows that the halogenated ether anesthetics isoﬂurane, sevoﬂurane, and enﬂurane are also bound to the hydrophobic core of
the four-a-helix bundle, using isothermal titration calorimetry. Isoﬂurane and sevoﬂurane both bound to the four-a-helix bundle
with Kd values of 140 6 10 mM, whereas enﬂurane bound with a Kd value of 240 6 10 mM. The DH8 values associated with
isoﬂurane, sevoﬂurane, and enﬂurane binding were –7.7 6 0.1 kcal/mol, 8.2 6 0.2 kcal/mol, and –7.2 6 0.1 kcal/mol,
respectively. The DS8 values accompanying isoﬂurane, sevoﬂurane, and enﬂurane binding were 8.5 cal/mol K, 10.4 cal/mol
K, and 8.0 cal/mol K, respectively. The results indicate that the hydrophobic core of (Aa2-L38M)2 is able to accommodate
three modern ether anesthetics with Kd values that approximate their clinical EC50 values. The DH8 values point to the
importance of polar interactions for volatile general anesthetic binding, and suggest that hydrogen bonding to the ether oxygens
may be operative.
INTRODUCTION
A molecular understanding of volatile general anesthetic
mechanisms of action will require structural descriptions of
anesthetic-protein complexes. Because the in vivo sites of
action remain to be determined, the structural features of
anesthetic binding sites on proteins are being explored using
well deﬁned model systems, such as the serum albumins and
four-a-helix bundle proteins (Eckenhoff and Johansson,
1997). Studies with these model systems have suggested that
volatile general anesthetics preferentially bind to preexisting
appropriately sized packing defects, or cavities, within the
protein matrix. In addition, favorable polar interactions with
hydrophobic core side chains can enhance anesthetic binding
afﬁnity (Johansson et al., 2000; Manderson and Johansson,
2002).
Previous work has demonstrated that the halogenated
alkane volatile anesthetics halothane and chloroform bind to
the designed packing defect in the hydrophobic core of the
four-a-helix bundle (Aa2-L38M)2 with dissociation con-
stants that are comparable to their clinical EC50 values
(Johansson et al., 2000, 2003). Because halogenated ether
anesthetics are currently used primarily in the United States
and Europe it is of interest to determine whether these
molecules can also associate with the current four-a-helix
bundle design. In contrast to halothane and chloroform, these
halogenated ether anesthetics are not efﬁcient quenchers of
tryptophan ﬂuorescence, precluding the use of this spectro-
scopic approach (Johansson et al., 1995) to monitor ane-
sthetic binding. The current study therefore uses isothermal
titration calorimetry to examine the binding of three
halogenated ether anesthetics to the four-a-helix bundle
(Aa2-L38M)2. In addition to providing values for dissoci-
ation constants, isothermal titration calorimetry has the
distinct advantage of allowing both the enthalpic and
entropic contributions to binding to be resolved (Leavitt
and Friere, 2001).
To calibrate the results against earlier work using
tryptophan ﬂuorescence quenching, isothermal titration
calorimetry was used initially to determine the energetics
of halothane binding to the four-a-helix bundle. The binding
of the ether anesthetics isoﬂurane, sevoﬂurane, and enﬂurane
to the four-a-helix bundle (Aa2-L38M)2 was then charac-
terized thermodynamically, after having shown that iso-
thermal titration calorimetry and tryptophan ﬂuorescence
quenching gave comparable quantitative results with regard
to halothane binding.
MATERIALS AND METHODS
9-Fluorenylmethoxycarbonyl (Fmoc) amino acids and Fmoc 2,4-dimethox-
ybenzhydrylamide resin were purchased from Perkin Elmer (Foster City,
CA). Halothane (2-bromo-2-chloro-1,1,1-triﬂuoroethane) was obtained
from Halocarbon Laboratories (Hackensack, NJ). The thymol preservative
present in the commercial halothane was removed with an aluminum oxide
column (Johansson et al., 1995). Enﬂurane (2-chloro-1,1,2-triﬂuoroethyl
diﬂuoromethyl ether) was obtained from Anaquest (Madison, WI).
Isoﬂurane (1-chloro-2,2,2-triﬂuoroethyl diﬂuoromethyl ether) was pur-
chased from Ohmeda PPD, Inc. (Liberty Corner, NJ), and sevoﬂurane
(ﬂuoromethyl 2,2,2-triﬂuoro-1-(triﬂuoromethyl) ethyl ether from Abbott
Laboratories (North Chicago, IL). All other chemicals were of reagent grade.
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Peptide synthesis and preparation
The peptide Aa2-L38M (Johansson et al., 2000) was assembled as a C-
terminus carboxyamide on a 0.25-mM scale using Fmoc amino acids and
Fmoc 2,4-dimethoxybenzhydrylamide resin on an Applied Biosystems
model 433A solid-phase peptide synthesizer (Perkin Elmer, Foster City,
CA). Crude peptides were puriﬁed to homogeneity using reversed-phase C18
HPLC with aqueous-acetonitrile gradients containing 0.1% (v/v) 2,2,2-
triﬂuoroacetic acid. Laser desorption mass spectrometry conﬁrmed the
peptide identity.
Isothermal titration calorimetry
Isothermal titration calorimetry was performed using a MicroCal VP-ITC
titration microcalorimeter (Northampton, MA) at 208C. The four-a-helix
bundle (Aa2-L38M)2 at a concentration of 123 mM in 130 mM NaCl, pH
7.0, was placed in the 1.4-ml calorimeter cell, and anesthetic (5 mM in 130
mMNaCl, pH 7.0) was added sequentially in 10 ml aliquots (for a total of 29
injections) at 5-min intervals. The heat of reaction per injection (micro-
calories per second) was determined by integration of the peak areas using
the Origin Version 5.0 software (1998). This software provides the best-ﬁt
values of the heat of binding (DH8), the stoichiometry of binding (n), and the
dissociation constant (Kd) from plots of the heat evolved per mol of
anesthetic injected versus the anesthetic/(Aa2-L38M)2 molar ratio (Wise-
man et al., 1989). The heats of dilution were determined in parallel control
experiments by injecting either 130 mM NaCl, pH 7.0, into a 123 mM four-
a-helix bundle (Aa2-L38M)2 solution or 5 mM anesthetic (in 130 mM
NaCl, pH 7.0) into the 130-mM NaCl, pH 7.0, solution. These heats of
dilution are subtracted from the corresponding four-a-helix bundle-
anesthetic binding experiments before curve-ﬁtting.
The overall shape of the titration curve depends upon the c value ([(Aa2-
L38M)2]/Kd) (Wiseman et al., 1989) and is rectangular for high c values
(>500) and ﬂat for low c values (<0.1). Earlier work using tryptophan
ﬂuorescence quenching indicates that halothane binds to the four-a-helix
bundle (Aa2-L38M)2 with a Kd of 2006 10 mM (Johansson et al., 2000). To
achieve a c value in the ideal range for isothermal titration calorimetry
(5–50) would therefore require prohibitively high concentrations of protein
(on the order of 1–10 mM). The four-a-helix bundle concentration used was
123 mM (c ¼ 0.6), resulting in a shallow titration curve for halothane.
Because the hydrophobic core of the four-a-helix bundle (Aa2-L38M)2
contains two identical binding sites for the anesthetics (Fig. 1), n was set as
1.0 so that deconvolution of the resulting isotherms only required the Kd and
DH8 values to be minimized. Allowing all three variables to ﬂoat
simultaneously may be associated with more variable results because of
the potential for multiple minima (Wiseman et al., 1989).
RESULTS
Binding of the volatile anesthetic halothane to
the hydrophobic core of the four-a-helix bundle
(Aa2-L38M)2
A representative calorimetric titration at pH 7.0 of the four-
a-helix bundle (Aa2-L38M)2 with halothane is shown in
FIGURE 1 (A) Modeled structure of the synthetic four-
a-helix bundle. The cylinders represent the two 27-residue
amphiphilic a-helical portions of each 62-residue di-a-
helical peptide, joined by an eight-residue glycine linker.
Black and white halves of each cylinder represent
hydrophilic and hydrophobic residues, respectively. (B)
End-on view of anti four-a-helix bundle, showing the
interaction of the hydrophobic core residues at the heptad
a and d positions. The dashed lines indicate how
successive hydrophobic core layers are composed of two
a and two d residues. (C) An opened-out and ﬂattened
representation of the (Aa2-L38M)2 bundle illustrating the
amino acids present at the hydrophobic heptad a and
d positions. There are a total of eight hydrophobic core
layers, each composed of two a and two d position
residues. The heptad a position W15 residues are shaded.
Equivalent binding sites for anesthetic molecules reside in
hydrophobic core layers III and VI where larger leucines
were replaced with smaller alanines (Johansson et al.,
1998).
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Fig. 2. Each peak in the binding isotherm (Fig. 2, upper
panel) represents a single injection of halothane. The
negative deﬂections from the baseline on addition of
halothane indicate that heat was evolved (an exothermic
process). The enthalpy change associated with each injection
of halothane was plotted versus the halothane/(Aa2-L38M)2
molar ratio (Fig. 2, lower panel), and the DH8, Kd, the free
energy change associated with binding (DG8), and the
change in entropy associated with binding (DS8) were
determined from the plots. The Kd value of 60 6 5 mM is
quite comparable to the value of 200 6 10 mM obtained
using tryptophan ﬂuorescence quenching (Johansson et al.,
2000), supporting the validity of the results. The other
thermodynamic parameters underlying halothane binding
to the four-a-helix bundle (Aa2-L38M)2 are given in
Table 1.
Binding of the volatile anesthetics isoﬂurane,
sevoﬂurane, and enﬂurane to the hydrophobic
core of the four-a-helix bundle (Aa2-L38M)2
Representative calorimetric titrations at pH 7.0 of the four-a-
helix bundle (Aa2-L38M)2 with isoﬂurane, sevoﬂurane, and
enﬂurane are shown in Figs. 3–5. Each peak in the binding
isotherms (Figs. 3–5, upper panels) represents a single
injection of anesthetic. The negative deﬂections from the
FIGURE 2 Titration of the four-a-helix bundle (Aa2-L38M)2 with
halothane, showing the calorimetric response as successive injections of
ligand are added to the reaction cell. Panel B depicts the binding isotherm of
the calorimetric titration shown in panel A. The continuous line represents
the least-squares ﬁt of the data to a single-site binding model.
TABLE 1 Dissociation constants and thermodynamic data
for binding of volatile general anesthetics to the four-a-helix
bundle (Aa2-L38M)2
Anesthetic Kd (mM) DG8 (kcal/mol) DH8 (kcal/mol) DS8 (eu)*
Halothane 60 6 5 5.7 6 0.1 7.7 6 0.2 6.9
Isoﬂurane 140 6 10 5.2 6 0.1 7.7 6 0.1 8.5
Sevoﬂurane 140 6 10 5.2 6 0.1 8.2 6 0.2 10.4
Enﬂurane 240 6 10 4.9 6 0.1 7.2 6 0.1 8.0
*The entropy unit (eu) is cal/mol K.
FIGURE 3 Titration of the four-a-helix bundle (Aa2-L38M)2 with
isoﬂurane, showing the calorimetric response as successive injections of
ligand are added to the reaction cell. Panel B depicts the binding isotherm of
the calorimetric titration shown in panel A. The continuous line represents
the least-squares ﬁt of the data to a single-site binding model.
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baseline on addition of anesthetic in each case indicate that
heat was evolved. The enthalpy change associated with each
injection of anesthetic was plotted versus the anesthetic/
(Aa2-L38M)2 molar ratio (Figs. 3–5, lower panels), and the
DH8, Kd, DG8, and DS8 were determined from the plots. The
Kd values for isoﬂurane, sevoﬂurane, and enﬂurane binding
to the four-a-helix bundle (Aa2-L38M)2 were 140 6 10
mM, 140 6 10 mM, and 240 6 10 mM, respectively. The
other thermodynamic parameters underlying the binding of
isoﬂurane, sevoﬂurane, and enﬂurane to the four-a-helix
bundle (Aa2-L38M)2 are given in Table 1.
The four-a-helix bundle (Aa2-L38M)2 follows
the Meyer-Overton rule
The Meyer-Overton rule has played a central role in the ﬁeld
of general anesthetic mechanisms research (Miller, 1985).
This relationship shows that the olive oil/gas partition
coefﬁcients of anesthetic molecules correlate with their
potency in animals. The ability of model proteins to obey
the Meyer-Overton rule is used as an indication of how well
they mimic the in vivo sites of anesthetic action (Miller,
1985). Fig. 6 shows a plot of the experimentally determined
dissociation constants for halothane, chloroform, isoﬂurane,
sevoﬂurane, and enﬂurane binding to the hydrophobic core of
the four-a-helix bundle (Aa2-L38M)2 versus human or
whole animal potency (EC50) data. Although limited to six
data points, the binding site in the hydrophobic core of the
four-a-helix bundle (Aa2-L38M)2 behaves in accord with the
Meyer-Overton rule, suggesting that it represents a reasonable
model of the actual central nervous system targets.
DISCUSSION
Although the in vivo sites of action of the volatile general
anesthetics remain to be determined, it is currently argued
FIGURE 4 Titration of the four-a-helix bundle (Aa2-L38M)2 with
sevoﬂurane, showing the calorimetric response as successive injections of
ligand are added to the reaction cell. Panel B depicts the binding isotherm of
the calorimetric titration shown in panel A. The continuous line represents
the least-squares ﬁt of the data to a single-site binding model.
FIGURE 5 Titration of the four-a-helix bundle (Aa2-L38M)2 with
enﬂurane, showing the calorimetric response as successive injections of
ligand are added to the reaction cell. Panel B depicts the binding isotherm of
the calorimetric titration shown in panel A. The continuous line represents
the least-squares ﬁt of the data to a single-site binding model.
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that membrane proteins in the central nervous system
represent likely targets (Franks and Lieb, 1994; Krasowski
and Harrison, 1999). Based upon the few x-ray crystal
structures that are available it is evident that the trans-
membrane domains of membrane proteins typically consist
of bundles of a-helices (Doyle et al., 1998; Toyoshima et al.,
2000; Bass et al., 2002; Dutzler et al., 2003). In addition,
there is evidence that volatile general anesthetics interact
directly with the transmembrane segments of ligand-gated
ion channels (Eckenhoff, 1996; Mascia et al., 2000; Ishizawa
et al., 2002). The ability of four-a-helix bundles to model the
transmembrane domains is therefore being examined to
provide detailed structural descriptions of anesthetic-protein
interactions with the ultimate goal of understanding the
mechanisms of anesthetic action.
Techniques that allow the direct measurement of volatile
anesthetic binding to protein targets have been introduced
during the past decade. These methods rely on 19F-NMR
spectroscopy (Dubois and Evers, 1992; Dubois et al., 1993),
photoafﬁnity labeling with halothane (Eckenhoff and Shu-
man, 1993), and ﬂuorescence spectroscopy (Johansson et al.,
1995; Manderson and Johansson, 2002). Isothermal titration
calorimetry was ﬁrst introduced a little over a decade ago
(Wiseman et al., 1989) and is increasingly being used to
study the thermodynamics of a broad range of molecular
interactions. One prior study (Ueda and Yamanaka, 1997)
has reported the use of isothermal titration calorimetry to
characterize the binding of chloroform to bovine serum
albumin. A Kd of 0.47 mM was determined for chloroform
binding to bovine serum albumin and the molar heat of
binding was –2.5 6 0.1 kcal/mol.
The current study was designed to determine whether the
hydrophobic core of the four-a-helix bundle (Aa2-L38M)2 is
able to bind the halogenated ether anesthetics isoﬂurane,
sevoﬂurane, and enﬂurane. Earlier studies have shown that
this four-a-helix bundle design is able to bind both halothane
and chloroform with dissociation constants that approximate
their respective clinical EC50 values (Johansson et al., 2000,
2003). These studies relied on the ability of both halothane
and chloroform to effectively quench the ﬂuorescence of
W15 located in the hydrophobic core of the four-a-helix
bundle. In the current study, isothermal titration calorimetry
was used to deﬁne the binding energetics associated with
halogenated ether anesthetic binding. The results indicate
that the hydrophobic core of (Aa2-L38M)2 is able to
accommodate three modern ether anesthetics with Kd values
that approximate their clinical EC50 values of 260–490 mM
(Krasowski and Harrison, 1999). The results therefore
suggest that the same site on a protein can bind structurally
diverse volatile general anesthetics with afﬁnities compara-
ble to their clinical EC50 values. The DH8 values point to the
importance of polar interactions for anesthetic binding, and
suggest that hydrogen bonding to the ether oxygen may be
operative.
Isoﬂurane has been shown to bind to bovine serum
albumin with Kd values of 1.46 0.2 and 1.36 0.2 mM using
19F-NMR spectroscopy (Dubois and Evers, 1992; Xu et al.,
2000). Using a competitive photoafﬁnity labeling approach,
Eckenhoff and Shuman (1993) reported a Kd value of 1.5 6
0.2 mM for isoﬂurane binding to bovine serum albumin.
Similarly, a tryptophan ﬂuorescence anisotropy study de-
termined that isoﬂurane bound to bovine serum albumin with
a Kd of 1.6 6 0.4 mM (Johansson et al., 1999). In addition,
isoﬂurane has been shown to bind to nicotinic acetylcholine
receptors from Torpedo nobiliana with an average Kd value
of 0.36 6 0.03 mM using 19F-NMR spectroscopy and gas
chromatography (Xu et al., 2000). Sevoﬂurane binds to
bovine serum albumin with a Kd value of 4.5 6 0.6 mM as
FIGURE 6 Meyer-Overton plot of the human or whole
animal potency data versus the experimental dissociation
constant for binding to the four-a-helix bundle (Aa2-
L38M)2. The halothane clinical EC50 value in man is 250
mM (Franks and Lieb, 1994), the chloroform EC50 value in
dogs is 1.2 6 0.2 mM (Eger et al., 1969), and the EC50
values in humans for isoﬂurane, sevoﬂurane, and enﬂurane
are 260 mM, 260 mM, and 490 mM, respectively
(Krasowski and Harrison, 1999). Two data points are for
halothane, using the current Kd value and that of 200 6 10
mM determined using ﬂuorescence spectroscopy as re-
ported earlier (Johansson et al., 2000). Note that the
isoﬂurane and sevoﬂurane data points superimpose. The
least-squares linear regression correlation coefﬁcient is
0.982.
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determined using 19F-NMR spectroscopy (Dubois et al.,
1993). No report that directly addresses enﬂurane binding to
proteins is currently available in the literature. The four-a-
helix bundle (Aa2-L38M)2 therefore binds the halogenated
ethers;10-fold more tightly than serum albumin. Of interest
is that this relatively simple protein is able to bind the
structural isomers enﬂurane and isoﬂurane with the relative
afﬁnities that mirror their respective in vivo potencies.
For the binding of all four volatile general anesthetics to
the four-a-helix bundle (Aa2-L38M)2, DH8 was somewhat
more negative than DG8 (Table 1). Because DG8 ¼ DH8 -
TDS8, it follows that the entropy term will also be negative
under these conditions. The binding of all four volatile
general anesthetics to the four-a-helix bundle is therefore
driven by enthalpy, whereas the entropy term is counter-
acting complex formation. This may be explained by the fact
that the dissociation constants reﬂect relatively tight binding
of anesthetic molecules to the four-a-helix bundle, compared
to other proteins where direct binding has been demonstrated
(Dubois and Evers, 1992; Dubois et al., 1993; Eckenhoff and
Shuman, 1993, Johansson et al., 1995). Under these con-
ditions, complex formation leads to a reduction in the degrees
of freedom of both the anesthetic and the side chains at the
binding site on the four-a-helix bundle, yielding a net entropic
loss (Smithrud et al., 1991). As shown in Table 1, the binding
of the anesthetic ethers isoﬂurane, sevoﬂurane, and enﬂurane
to the four-a-helix bundle was associated with a greater
entropic loss compared to halothane binding. Because the
anesthetic ethers are predicted to be able to accept hydrogen
bonding partners in the binding site on the four-a-helix
bundle, this should impose additional geometric constraints
on the complex that may be absent in the case of halothane,
where more traditional hydrogen bonding interactions should
be lacking. Furthermore, the dehydration of halothane that
accompanies binding to the four-a-helix bundle may be
associated with a greater net entropy increase compared to
that associated with anesthetic ether dehydration.
Isothermal titration calorimetry may prove to be of
considerable value as a method for examining the inter-
actions of the volatile general anesthetics with a variety of
proteins, including potential membrane targets. An advan-
tage over 19F-NMR is that anesthetic molecules that are not
ﬂuorinated, such as nitrous oxide and cyclopropane, can be
studied. Photoafﬁnity labeling has the disadvantage of being
limited to studies on halothane, although the binding of other
anesthetics to proteins can be examined using competitive
approaches (Eckenhoff and Shuman, 1993). Compared to the
ﬂuorescence quenching technique (Johansson et al., 1995),
isothermal titration calorimetry has the advantage of
allowing nonquenching, or poorly quenching, anesthetics
to be studied, as in the current manuscript. The main
limitation of isothermal titration calorimetry is that high
protein concentrations are required, because of the inherent
relatively weak energetics of the interactions of volatile
general anesthetics with macromolecules.
Recent efforts to crystallize the four-a-helix bundle (Aa2-
L38M)2 have met with success and heavy atom derivatives
are currently being investigated. The current results suggest
that this four-a-helix bundle represents an attractive system
for atomic-level structural studies in the presence of bound
anesthetic. Such studies will provide much needed insight
into how volatile anesthetics interact with biological macro-
molecules, and will provide guidelines regarding the general
architecture of binding sites on central nervous system
proteins.
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